154 related articles for article (PubMed ID: 36483630)
1. Effect of Cepharanthine on the Stemness of Lung Squamous Cell Carcinoma Based on Network Pharmacology and Bioinformatics.
Liu B; Deng JX
Biomed Res Int; 2022; 2022():5956526. PubMed ID: 36483630
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of
Wu WY; Jiao X; Song WX; Wu P; Xiao PQ; Huang XF; Wang K; Zhan SF
Front Endocrinol (Lausanne); 2023; 14():1187882. PubMed ID: 37347115
[TBL] [Abstract][Full Text] [Related]
3. Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.
Tu H; Li J; Xu W; Wang Z; Wang L
Altern Ther Health Med; 2023 Oct; 29(7):148-154. PubMed ID: 37442189
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the molecular mechanism of cepharanthine against COVID-19, based on a network pharmacology strategy combined with RNA-sequencing analysis, molecular docking, and molecular dynamics simulation.
Liu J; Sun T; Liu S; Liu J; Fang S; Tan S; Zeng Y; Zhang B; Li W
Comput Biol Med; 2022 Dec; 151(Pt A):106298. PubMed ID: 36403355
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of Tetrastigma hemsleyanum Diels&Gilg against lung squamous cell carcinoma: From computational biology and experimental validation.
Li P; Wang C; Chen G; Han Y; Lu H; Li N; Lv Y; Chu C; Peng X
J Ethnopharmacol; 2024 Sep; 331():118326. PubMed ID: 38750988
[TBL] [Abstract][Full Text] [Related]
6. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
7. Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.
Zhang T; Yang H; Sun B; Yao F
Aging (Albany NY); 2021 Jan; 13(3):3819-3842. PubMed ID: 33428598
[TBL] [Abstract][Full Text] [Related]
8. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
9. Exploring the hub genes and mechanisms of Daphne altaica treating esophageal squamous cell carcinoma based on network pharmacology and bioinformatics analysis.
Hailati S; Talihati Z; Abudurousuli K; Han MY; Nuer M; Khan N; Maihemuti N; Simayi J; Dilimulati D; Nueraihemaiti N; Zhou W
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8467-8481. PubMed ID: 37087696
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CHRNA6 in the Immune Response in Lung Squamous Cell Carcinoma and its Potential as a Drug Target for the Disease.
Zhang F; Zhang M; Yuan X; Tao Y; Wang J
Curr Pharm Des; 2023; 29(26):2091-2100. PubMed ID: 37680128
[TBL] [Abstract][Full Text] [Related]
11. The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19.
Jiang P; Ye J; Jia M; Li X; Wei S; Li N
Front Pharmacol; 2022; 13():960267. PubMed ID: 35935817
[No Abstract] [Full Text] [Related]
12. Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.
Yan D; Chen Y
Sci Rep; 2021 Apr; 11(1):9020. PubMed ID: 33907270
[TBL] [Abstract][Full Text] [Related]
13. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis.
Zhang R; Zhang TT; Zhai GQ; Guo XY; Qin Y; Gan TQ; Zhang Y; Chen G; Mo WJ; Feng ZB
World J Surg Oncol; 2018 Jun; 16(1):109. PubMed ID: 29914539
[TBL] [Abstract][Full Text] [Related]
15. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
Zhang W; Yang Z; Zhou F; Wei Y; Ma X
Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
[TBL] [Abstract][Full Text] [Related]
16. Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation.
Zhuang Z; Lin T; Luo L; Zhou W; Wen J; Huang H; Liu Z; Lin L
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33506873
[TBL] [Abstract][Full Text] [Related]
17. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
18. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
[TBL] [Abstract][Full Text] [Related]
19. Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis.
Gao M; Kong W; Huang Z; Xie Z
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340320
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.
Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY
Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
